Every day, more lives are transformed all over the world – one healthy habit at a time. Read the latest about how Medifast and the OPTAVIA® movement is impacting people’s lives.
"If low carbohydrate is what the consumer wants, that is what we will give them," says Brad MacDonald, CEO of Medifast. "Industry research has determined that the low-carb craze is a trend that could last for many years to come. We believe this line of clinically proven products will give us a huge advantage over the competition."
The company is also proud to announce that its Medifast Plus for Diabetics Shakes recently received an official patent (patent number 6,706,697) from the United States Patent and Trademark Office. The Company's Diabetic shake formulation is protected for twenty years from others producing, manufacturing and marketing goods incorporating the product. The Company intends to build its intellectual property through additional patents on its other leading line of products.
In addition, the Company has continued to expand its line of great tasting meal replacement supplements. Most recently the Company launched a Fruit and Nut Granola Bar and Creamy Cappuccino, Tropical Punch and Cranberry Mango Punch meal replacements; all with 24 essential vitamins and minerals and less than 160 calories per serving. In addition the company has added a Garden Vegetable Cracker to its snack offerings. The Company has continued to serve its customers through the development of new products to help its customers avoid taste fatigue and boredom. Medifast has one of the most extensive low- calorie, balanced carbohydrate and soy-based products in the weight loss industry.
"Our extensive product line and clinically proven results is what keeps our customers coming back," says MacDonald. "We have grown to over 100 product offerings in less than six months."
This release contains forward-looking statements, which may involve known, and unknown risks, uncertainties and other factors that may cause Medifast's actual results and performance in future periods to be materially different from any future results or performance suggested by these statements. Medifast cautions investors not to place undue reliance on forward-looking statements, which speak only to management's expectation on this date.
SOURCE: Medifast, Inc.
CONTACT: Jeremy Hunt, Investor Relations Specialist, +1-410-504-8196, or
Casey Seward, Public Relations Manager, +1-410-504-8154, both of Medifast; or
Ken Sgro, CEOcast, Inc., for Medifast, +1-212-732-4300
Web site: http://www.medifastdiet.com/